CATX - Perspective Therapeutics, Inc.
4.97
-0.130 -2.616%
Share volume: 1,054,090
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$5.10
-0.13
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-13-2024 | 11-12-2024 | 03-28-2025 | 05-12-2025 | 08-13-2025 | 11-10-2025 | |
| Assets | ||||||||
| Total Assets | 278.286 M | 385.919 M | 391.153 M | 341.101 M | 329.349 M | 310.725 M | 294.825 M | |
| Current Assets | 188.200 M | 294.237 M | 270.172 M | 231.160 M | 215.742 M | 195.958 M | 178.500 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 38.531 M | 40.865 M | 41.404 M | 165.336 M | 167.296 M | 162.729 M | 147.375 M | |
| Total Receivables | 999.000 K | 142.000 K | 217.000 K | 116.000 K | 0.000 | 0.000 | 0.000 | |
| Current Cash | 142.117 M | 252.004 M | 226.443 M | 61.580 M | 44.406 M | 28.849 M | 26.762 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 14.302 M | 14.747 M | 43.792 M | 57.321 M | 61.247 M | 62.599 M | 64.351 M | |
| Other Assets | 75.784 M | 76.935 M | 77.189 M | 52.620 M | 52.360 M | 52.168 M | 51.974 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 278.286 M | 385.919 M | 391.153 M | 341.101 M | 329.349 M | 310.725 M | 294.825 M | |
| Total liabilities | 48.395 M | 44.922 M | 62.682 M | 50.433 M | 44.704 M | 45.033 M | 52.609 M | |
| Total current liabilities | 14.503 M | 10.610 M | 28.143 M | 18.230 M | 12.679 M | 12.986 M | 20.618 M | |
| Accounts Payable | 6.027 M | 6.127 M | 21.813 M | 10.343 M | 8.734 M | 7.048 M | 13.148 M | |
| Other liabilities | 27.637 M | 28.069 M | 28.309 M | 28.083 M | 27.919 M | 27.955 M | 27.913 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.663 M | 1.651 M | 1.638 M | 1.625 M | 1.611 M | 1.597 M | 1.583 M | |
| Other liabilities | 27.637 M | 28.069 M | 28.309 M | 28.083 M | 27.919 M | 27.955 M | 27.913 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 229.891 M | 340.997 M | 328.471 M | 290.668 M | 284.645 M | 265.692 M | 242.216 M | |
| Common stock | 394.615 M | 517.425 M | 520.021 M | 522.438 M | 534.522 M | 537.070 M | 539.452 M | |
| Retained earnings | -164.724 M | -176.428 M | -191.550 M | -231.719 M | -249.896 M | -271.381 M | -297.350 M |